Roth Capital lowered the firm’s price target on Hyster-Yale (HY) to $40 from $50 and keeps a Buy rating on the shares after its Q3 results. Conditions stay challenging given the impact of market uncertainties and tariffs on both customer decision-making and underlying product profitability, as forward visibility looks much more limited currently, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HY:
